Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease

Class:IdLiteratureReference:417822
_displayNameInhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease
_timestamp2009-04-14 08:45:27
author[Person:417931] Kellerman, D
[Person:417925] Evans, R
[Person:417893] Mathews, D
[Person:417885] Shaffer, C
created[InstanceEdit:417833] Jassal, Bijay, 2009-04-14
journalAdv Drug Deliv Rev
pages1463-74
pubMedIdentifier12458155
titleInhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease
volume54
year2002
(literatureReference)[Reaction:417927] P2Y2 receptor binds ATP and UTP [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease (417822)